NPPA Caps Retail Price of Calcium and Vitamin D3 Tablets at Rs 8.93

Susmita Roy

NPPA Caps Retail Price of Calcium and Vitamin D3 Tablets at Rs 8.93

Written By : Susmita Roy Published On 2026-07-15T22:41:56+05:30 | Updated On 15 July 2026 10:41 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Calcium and Vitamin D3 Tablets IP under the provisions of the Drugs (Prices Control) Order (DPCO), 2013. The price has been notified through an order issued by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.

As per the latest notification, the retail price of Calcium and Vitamin D3 Tablets IP, containing Elemental Calcium 500 mg (as Calcium Carbonate IP) and Vitamin D3 IP 2000 IU, has been fixed at Rs. 8.93 per tablet, exclusive of applicable Goods and Services Tax (GST).

The price is applicable to the formulation manufactured by Akums Drugs & Pharmaceuticals Ltd. and marketed by Eris Lifesciences Ltd.

Also Read: NPPA Revises Ceiling Price of Anti-Rabies Immunoglobulin Injection

The notice stated in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 5249(E) dated 11th November, 2022 and S.O. 3516(E) dated 30th June, 2026 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Calcium and Vitamin D3 Tablets IP	Each film coated tablet contains: Calcium Carbonate IP equivalent to Elemental Calcium 500 mg• Vitamin D3 IP 2000 IU	1 Tablet	Manufacturer: M/s. Akums Drugs & Pharmaceuticals Ltd.Marketing Company: M/s. Eris Lifesciences Ltd.	8.93

The notification further added,

(a) The manufacturer, as mentioned in column (5) of the table above, of formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price not exceeding the price as specified in column (6) of the table above.

(b) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(c) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(d) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

To view the order, click the link below:

https://medicaldialogues.in/pdf_upload/2026/07/12/274308-359303.pdf

nppacalcium and vitamin d3 tabletscalcium carbonateelemental calcium 500 mgvitamin d3 2000 iuakums drugs and pharmaceuticalseris lifesciencesdrug pricingprice fixationessential commodities act

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.